2014 Plum Biology Annual Report: Net Profit of 500 Million Amino Acid Income Growth

On the evening of March 17,, Plum Bio released its 2014 annual reportIn 2014, the Company achieved operating income of RMB9.865 billion, up 26.79% YoY, of which the domestic market achieved operating income of RMB7,086 million, up 32.69% YoY, and the international market realized operating income of RMB2,779 million, up 13.90% YoYThe most important driver of business revenue growth is product sales growthRealized net profit attributable to the company's owners was RMB500 million, an increase of 23.92 percent year-on-yearvFF
Revenue in the amino acid industry was RMB3.546 billion, up 63.76 percent YoY, and gross margin increased by 6.07 percentage points YoY, mainly due to the increase in Xinjiang plum production and the increase in prices of Susine products, which led to the increase in gross marginvFF
As of December 31, 2014, Tongliao Meihua's main products were MSG and amino acids, achieving operating income of RMB6.218 billion and net profit of RMB341 millionXinjiang plum products are amino acids, achieving operating income of 2,999 million yuan, net profit of 66.63 million yuanvFF
After multiple rounds of production capacity expansion, the global amino acid industry has reached a historical peak, saturated market space, phased overcapacity, homogenization of competition, the overall decline of the overall economy, resulting in the overall price of the amino acid market depressed, the game between leading enterprises intensifiedThe regional market represented by Europe and the United States, competing for trade protectionism against MsMIG and Huangyuan gum products exported to China, and frequently launched anti-dumping investigationsvFF
In order to obtain competitive advantage, enterprises, on the one hand, reduce procurement costs and strengthen distribution capacity, on the other hand, improve the technical level and reduce production costs, in order to enhance competitiveness and market shareThe stronger the amino acid market, the weaker the weaker the trend, the product production from the dispersion tends to concentrate, the new oligarch market pattern began to appearIt is expected that the integration of competition in 2015 will continue to be the main play between enterprises, and competition will gradually promote the concentration of enterprisesvFF
The future company continues to adhere to the "world-leading amino acid enterprises, to do China's leading condiment enterprises" strategic objectives, will be based on the biofermentation industry, and constantly increase the proportion of amino acid products, selective water test into the field of medicine, in the field of fresh flavor, feeding and medicinal amino acids, chemical fertilizer stake, brand flavoring products, pharmaceutical raw materials and other fields of developmentvFF
To acquire Epin Bio as an opportunity to carry out industry integration, enhance the position of the industry and competitive strengthUpon completion of the acquisition, the company will achieve complementary synergies with Ipin Bio in research and development, technology, channels, management and automation, and enhance the company's comprehensive strength and market influence in the amino acid market, so as to achieve stronger business coverage and enhance the ability of listed companies to resist risksvFFthe evening of March 17th, when Plum Bio released its 2014 annual reportIn 2014, the Company achieved operating income of RMB9.865 billion, up 26.79% YoY, of which the domestic market achieved operating income of RMB7,086 million, up 32.69% YoY, and the international market realized operating income of RMB2,779 million, up 13.90% YoYThe most important driver of business revenue growth is product sales growth Realized net profit attributable to the company's owners was RMB500 million, an increase of 23.92 percent year-on-year vFF
　　Revenue in the amino acid industry was RMB3.546 billion, up 63.76 percent YoY, and gross margin increased by 6.07 percentage points YoY, mainly due to the increase in Xinjiang plum production and the increase in prices of Susine products, which led to the increase in gross margin vFF
　　As of December 31, 2014, Tongliao Meihua's main products were MSG and amino acids, achieving operating income of RMB6.218 billion and net profit of RMB341 million Xinjiang plum products are amino acids, achieving operating income of 2,999 million yuan, net profit of 66.63 million yuan vFF
　　After multiple rounds of production capacity expansion, the global amino acid industry has reached a historical peak, saturated market space, phased overcapacity, homogenization of competition, the overall decline of the overall economy, resulting in the overall price of the amino acid market depressed, the game between leading enterprises intensified The regional market represented by Europe and the United States, competing for trade protectionism against Ms MIG and Huangyuan gum products exported to China, and frequently launched anti-dumping investigations vFF
　　In order to obtain competitive advantage, enterprises, on the one hand, reduce procurement costs and strengthen distribution capacity, on the other hand, improve the technical level and reduce production costs, in order to enhance competitiveness and market share The stronger the amino acid market, the weaker the weaker the trend, the product production from the dispersion tends to concentrate, the new oligarch market pattern began to appear It is expected that the integration of competition in 2015 will continue to be the main play between enterprises, and competition will gradually promote the concentration of enterprises vFF
　　The future company continues to adhere to the "world-leading amino acid enterprises, to do China's leading condiment enterprises" strategic objectives, will be based on the biofermentation industry, and constantly increase the proportion of amino acid products, selective water test into the field of medicine, in the field of fresh flavor, feeding and medicinal amino acids, chemical fertilizer stake, brand flavoring products, pharmaceutical raw materials and other fields of development vFF
　　To acquire Epin Bio as an opportunity to carry out industry integration, enhance the position of the industry and competitive strength Upon completion of the acquisition, the company will achieve complementary synergies with Ipin Bio in research and development, technology, channels, management and automation, and enhance the company's comprehensive strength and market influence in the amino acid market, so as to achieve stronger business coverage and enhance the ability of listed companies to resist risks vFF
Share it on feed